Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Present at Upcoming Investor Conferences

Friday, February 21, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced that members of its management team will be presenting at various upcoming investor conferences including B. Riley Securities Precision Oncology & Radiopharma Day and the TD Cowen 45th Annual Health Care Conference. These events will provide opportunities for stakeholders to engage with the company's leadership and gain insights into their ongoing commitments in the radiopharmaceutical field. Lantheus emphasizes its goal of improving patient outcomes by enabling clinicians to better detect and treat diseases.
Price reaction · baseline $80.84 (2025-02-20 close) · hit after-hours · 1 other LNTH headline(s) in the window, move may be shared
day 0 close · peak
-3.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Management team actively engaging with investors at multiple conferences.
  • Lantheus continues to be a leader in the radiopharmaceutical sector.
  • Commitment to improving patient outcomes through innovative solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor conferences.
B. Riley Securities Precision Oncology & Radiopharma Day in New York on February 28
TD Cowen 45th Annual Health Care Conference in Boston on March 4 at 2:30 pm ET
Leerink Global Healthcare Conference 2025 in Miami on March 11 at 1:40 pm ET
A live webcast will be available for the TD Cowen 45th Annual Health Care Conference and Leerink Global Healthcare Conference presentations on the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentations.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

What upcoming conferences will Lantheus attend?

Lantheus will present at investor conferences on February 28, March 4, and March 11.

Where can I watch Lantheus's conference presentations?

Live webcasts will be available on Lantheus's website during the conferences.

How long will the conference replays be available?

Replays of the webcasts will be available for at least 30 days after the events.

What is Lantheus’s focus in the biopharma sector?

Lantheus specializes in radiopharmaceuticals to improve patient outcomes in disease management.

Where is Lantheus headquartered?

Lantheus is headquartered in Bedford, Massachusetts, with offices in Canada and Sweden.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus investor conferences radiopharmaceuticals healthcare
Last updated: Feb 21, 2025

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →